The Gynecological Cancer Associated Thrombosis (GynCAT) Study
Recruiting now
Conditions studied: Cancer-associated Thrombosis, Venous Thromboembolism, Gynecologic Cancer, Ovarian Cancer, Cervix Cancer, Endometrial Cancer, Vaginal Cancer
In brief
GynCAT is a prospective cohort study that will be conducted on female patients with gynecologic malignancies scheduled for systemic antineoplastic treatment, aiming at development and validation of a Risk Assessment Model (RAM) for Venous Thromboembolism (VTE) in this specific population.
Key facts
- Study ID
- NCT06284343
- Run by
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- People needed
- 1800
- Starts
- 2024-04-15
- Expected to finish
- 2026-09-30
- Last updated by the study team
- 2024-09-19
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Female sex;
- Diagnosis of gynecologic neoplasm (ovarian, tubal, uterine, cervical, vaginal, vulvar neoplasm);
- Planned new line of systemic antineoplastic treatment;
- Age of 18 years or older;
- Accordance of Informed Consent.
You may not qualify if…
- Pregnant or breastfeeding women;
- Indication to receive therapeutic dose anticoagulant therapy (e.g., atrial fibrillation, mechanical heart valve);
- Diagnosis of symptomatic VTE at the time of screening for enrollment.
Where it is running
- Agostino Gemelli University Polyclinic Foundation IRCCS — Rome, Italy (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.